Weill Cornell Medicine researchers found that restricting telehealth prescriptions for opioid use disorder could keep thousands from accessing buprenorphine, a medication that helps people recover from addiction.
New research from Weill Cornell Medicine has uncovered a surprising culprit underlying cardiovascular diseases in obesity and diabetes – not the presence of certain fats, but their suppression.
The way DNA folds inside the nucleus of brain cells may hold the key to understanding a devastating form of brain cancer called glioblastoma, suggests a new preclinical study from Weill Cornell Medicine researchers.
A new analysis finds that Cornell Tech, its alumni and startups achieved $768 million in total economic impact in New York City in the 2023-24 fiscal year. That impact is expected to reach $1.5 billion by 2030.
A new study from Weill Cornell Medicine provides insights into how cells maintain the tiny end caps of chromosomes as they divide, a key process in keeping cells healthy.
Smolka, a biochemist and former interim director of the Weill Institute for Cell and Molecular Biology, will support life sciences across the university.
Sara Bronin is a professor of planning at Cornell University, an architect, attorney and founding director of the National Zoning Atlas. Her recent work with the Regional Plan Association analyzed the increasing risk of future flooding in New York City and how it may affect housing.
A new, error-corrected method for detecting cancer from blood samples is much more sensitive and accurate than prior methods and may be useful for monitoring disease status in patients following treatment.
